Deep-pocketed investors have adopted a bullish approach towards Johnson & Johnson JNJ, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JNJ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Johnson & Johnson. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 54% leaning bullish and 45% bearish. Among these notable options, 6 are puts, totaling $391,310, and 5 are calls, amounting to $251,653.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $150.0 to $165.0 for Johnson & Johnson over the recent three months.
Insights into Volume & Open Interest
In today's trading context, the average open interest for options of Johnson & Johnson stands at 795.6, with a total volume reaching 5,482.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Johnson & Johnson, situated within the strike price corridor from $150.0 to $165.0, throughout the last 30 days.
Johnson & Johnson 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | TRADE | BULLISH | 06/20/25 | $14.55 | $14.35 | $14.35 | $165.00 | $119.1K | 2.5K | 83 |
| JNJ | CALL | TRADE | BEARISH | 06/27/25 | $5.05 | $4.65 | $4.65 | $150.00 | $93.0K | 136 | 206 |
| JNJ | PUT | TRADE | BEARISH | 08/15/25 | $10.7 | $10.0 | $10.6 | $160.00 | $91.1K | 123 | 86 |
| JNJ | PUT | SWEEP | BULLISH | 05/23/25 | $0.82 | $0.81 | $0.81 | $150.00 | $81.1K | 1.4K | 3.2K |
| JNJ | CALL | SWEEP | BULLISH | 05/30/25 | $0.78 | $0.75 | $0.78 | $155.00 | $53.5K | 643 | 1.2K |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
In light of the recent options history for Johnson & Johnson, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Johnson & Johnson Standing Right Now?
- Currently trading with a volume of 3,885,401, the JNJ's price is up by 0.28%, now at $151.75.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 58 days.
Expert Opinions on Johnson & Johnson
1 market experts have recently issued ratings for this stock, with a consensus target price of $153.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Leerink Partners has revised its rating downward to Market Perform, adjusting the price target to $153.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
